[Experience in the use of biostator in the treatment of diabetes mellitus in children of the pubertal age].
The authors discuss the possibilities of the use of the apparatus "artificial pancreas biostator" in multiple modality treatment of patients suffering from type I diabetes. The own research data are provided. They are based on the use of the apparatus "biostator" in 62 children aged 9-15 years with diabetes mellitus in order to improve insulin therapy. After treatment sessions with the aid of the apparatus all the patients noted improvement of the well-being and abatement of the signs of diabetes mellitus lability. In some cases, the treatment using the apparatus promoted a more rapid attainment of disease compensation as compared to the application of conventional treatment methods. It has been shown that high insulin requirement of pubertal children with diabetes decompensation is determined in many respects by activation of the hypothalamus-pituitary-adrenal system.
Antsiferov
M B
MB
Karpova
L A
LA
Kolesnikova
G S
GS
Pankova
S S
SS
Starostina
E G
EG
D000293:Adolescent; D001786:Blood Glucose / Q000032:analysis; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005934:Glucagon / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007332:Insulin Infusion Systems; D007657:Ketone Bodies / Q000097:blood; D011627:Puberty
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007657:Ketone Bodies; D013006:Growth Hormone; D005934:Glucagon; D006854:Hydrocortisone
Opyt primeneniia "Biostatora" pri lechenii sakharnogo diabeta u deteĭ pubertatnogo vozrasta.